WO2002079495A3 - Genomics applications for modified oligonucleotides - Google Patents

Genomics applications for modified oligonucleotides

Info

Publication number
WO2002079495A3
WO2002079495A3 PCT/US2002/009691 US0209691W WO02079495A3 WO 2002079495 A3 WO2002079495 A3 WO 2002079495A3 US 0209691 W US0209691 W US 0209691W WO 02079495 A3 WO02079495 A3 WO 02079495A3
Authority
WO
WIPO (PCT)
Prior art keywords
modified oligonucleotides
nucleic acid
genomics applications
genomics
complexes
Prior art date
Application number
PCT/US2002/009691
Other languages
French (fr)
Other versions
WO2002079495A2 (en
Inventor
Eric B Kmiec
Howard B Gamper
Michael C Rice
Michael G Usher
Original Assignee
Univ Delaware
Eric B Kmiec
Howard B Gamper
Michael C Rice
Michael G Usher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Delaware, Eric B Kmiec, Howard B Gamper, Michael C Rice, Michael G Usher filed Critical Univ Delaware
Priority to AU2002303176A priority Critical patent/AU2002303176A1/en
Priority to EP02731183A priority patent/EP1414840A4/en
Priority to US10/260,150 priority patent/US7468244B2/en
Priority to EP02776053A priority patent/EP1446502A4/en
Priority to AU2002341898A priority patent/AU2002341898A2/en
Priority to PCT/US2002/031073 priority patent/WO2003027640A2/en
Publication of WO2002079495A2 publication Critical patent/WO2002079495A2/en
Priority to US10/672,735 priority patent/US7229767B2/en
Publication of WO2002079495A3 publication Critical patent/WO2002079495A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means

Abstract

Methods for the production and use of stable complexes of duplex nucleic acid molecules and oligonucleotides are presented. These complexes can be used for the detection and purification of a known nucleic acid target as well as the manipulation of a defined nucleic acid target sequence.
PCT/US2002/009691 2001-03-27 2002-03-27 Genomics applications for modified oligonucleotides WO2002079495A2 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
AU2002303176A AU2002303176A1 (en) 2001-03-27 2002-03-27 Genomics applications for modified oligonucleotides
EP02731183A EP1414840A4 (en) 2001-03-27 2002-03-27 Genomics applications for modified oligonucleotides
US10/260,150 US7468244B2 (en) 2001-09-27 2002-09-27 Polymorphism detection and separation
EP02776053A EP1446502A4 (en) 2001-09-28 2002-09-27 Polymorphism detection and separation
AU2002341898A AU2002341898A2 (en) 2001-09-28 2002-09-27 Polymorphism detection and separation
PCT/US2002/031073 WO2003027640A2 (en) 2001-09-28 2002-09-27 Polymorphism detection and separation
US10/672,735 US7229767B2 (en) 2001-03-27 2003-09-26 Genomics applications for modified OLIGO nucleotides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27914601P 2001-03-27 2001-03-27
US60/279,146 2001-03-27
US32582801P 2001-09-28 2001-09-28
US60/325,828 2001-09-28

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/260,150 Continuation-In-Part US7468244B2 (en) 2001-09-27 2002-09-27 Polymorphism detection and separation
US10/672,735 Continuation US7229767B2 (en) 2001-03-27 2003-09-26 Genomics applications for modified OLIGO nucleotides

Publications (2)

Publication Number Publication Date
WO2002079495A2 WO2002079495A2 (en) 2002-10-10
WO2002079495A3 true WO2002079495A3 (en) 2004-03-04

Family

ID=26959478

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/009691 WO2002079495A2 (en) 2001-03-27 2002-03-27 Genomics applications for modified oligonucleotides

Country Status (4)

Country Link
US (1) US7229767B2 (en)
EP (1) EP1414840A4 (en)
AU (1) AU2002303176A1 (en)
WO (1) WO2002079495A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002303176A1 (en) 2001-03-27 2002-10-15 University Of Delaware Genomics applications for modified oligonucleotides
US7468244B2 (en) 2001-09-27 2008-12-23 University Of Delaware Polymorphism detection and separation
AU2002341898A2 (en) * 2001-09-28 2003-04-07 University Of Delaware Polymorphism detection and separation
WO2007037676A1 (en) * 2005-09-29 2007-04-05 Keygene N.V. Method and means for targeted nucleotide exchange
US8951731B2 (en) * 2007-10-15 2015-02-10 Complete Genomics, Inc. Sequence analysis using decorated nucleic acids
EP2462230B1 (en) * 2009-08-03 2015-07-15 Recombinetics, Inc. Methods and compositions for targeted gene modification
US20150197787A1 (en) 2012-08-02 2015-07-16 Qiagen Gmbh Recombinase mediated targeted dna enrichment for next generation sequencing
CA3088071A1 (en) 2018-02-09 2019-08-15 Genentech, Inc. Oligonucleotides for modulating tmem106b expression
WO2024050304A1 (en) * 2022-08-29 2024-03-07 Illumina, Inc. Preparation and use of blocked substrates

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912340A (en) * 1995-10-04 1999-06-15 Epoch Pharmaceuticals, Inc. Selective binding complementary oligonucleotides
US5929043A (en) * 1995-01-31 1999-07-27 Pangene Corporation Recombinase mediated DNA therapies
US6107545A (en) * 1998-08-14 2000-08-22 Pioneer Hi-Bred International, Inc. Maize RAD6 genes and uses thereof
US6200812B1 (en) * 1997-03-21 2001-03-13 Sri International Sequence alterations using homologous recombination
US6335164B1 (en) * 1996-08-29 2002-01-01 Daikin Industries, Ltd. Methods for targeting, enriching, detecting and/or isolating target nucleic acid sequence using RecA-like recombinase

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888274A (en) * 1985-09-18 1989-12-19 Yale University RecA nucleoprotein filament and methods
EP0236491A1 (en) 1985-09-18 1987-09-16 Yale University RecA NUCLEOPROTEIN FILAMENT AND METHODS
JPS63109781A (en) 1986-10-27 1988-05-14 Rikagaku Kenkyusho Simple process for forming d-loop using reca protein-like protein in combination with anti-reca protein-like protein monoclonal antibody
DE3888653T2 (en) 1987-12-21 1994-07-07 Applied Biosystems Method and test kit for the detection of a nucleic acid sequence.
CA2037349C (en) * 1990-03-26 2008-06-17 James G. Wetmur Branch migration of nucleotides
US5223414A (en) * 1990-05-07 1993-06-29 Sri International Process for nucleic acid hybridization and amplification
US5273881A (en) * 1990-05-07 1993-12-28 Daikin Industries, Ltd. Diagnostic applications of double D-loop formation
CA2116215C (en) * 1990-05-07 1998-12-22 Tapestry Pharmaceuticals, Inc. Diagnostic applications of double d-loop formation
US5432272A (en) * 1990-10-09 1995-07-11 Benner; Steven A. Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
EP0556330B1 (en) 1990-11-09 2002-05-22 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services Method of targeting dna
US6136601A (en) * 1991-08-21 2000-10-24 Epoch Pharmaceuticals, Inc. Targeted mutagenesis in living cells using modified oligonucleotides
US5506098A (en) * 1991-09-04 1996-04-09 Daikin Industries, Ltd. In situ hybridization method
US5763240A (en) * 1992-04-24 1998-06-09 Sri International In vivo homologous sequence targeting in eukaryotic cells
AU4115693A (en) 1992-04-24 1993-11-29 Sri International In vivo homologous sequence targeting in eukaryotic cells
US20020090361A1 (en) * 1997-03-20 2002-07-11 David Zarling In vivo homologous sequence targeting in cells
WO1994003639A1 (en) 1992-08-04 1994-02-17 United States Biochemical Corporation NON-ISOTOPIC DETECTION OF NUCLEIC ACID SEQUENCES USING AN RecA LABEL
US5698397A (en) * 1995-06-07 1997-12-16 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5674698A (en) * 1992-09-14 1997-10-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US6159686A (en) * 1992-09-14 2000-12-12 Sri International Up-converting reporters for biological and other assays
US5736410A (en) * 1992-09-14 1998-04-07 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5468629A (en) * 1993-04-13 1995-11-21 Calhoun; Cornelia Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein
US5962426A (en) * 1993-06-25 1999-10-05 Yale University Triple-helix forming oligonucleotides for targeted mutagenesis
EP0733059B1 (en) * 1993-12-09 2000-09-13 Thomas Jefferson University Compounds and methods for site-directed mutations in eukaryotic cells
WO1995018236A1 (en) 1993-12-28 1995-07-06 Daikin Industries, Ltd. IN-SITU HYBRIDIZATION METHOD USING RecA PROTEIN AND RecA PROTEIN HAVING MARKER OR LIGAND FOR USE IN SAID METHOD
US5846719A (en) * 1994-10-13 1998-12-08 Lynx Therapeutics, Inc. Oligonucleotide tags for sorting and identification
US5776744A (en) * 1995-06-07 1998-07-07 Yale University Methods and compositions for effecting homologous recombination
US5670325A (en) * 1996-08-14 1997-09-23 Exact Laboratories, Inc. Method for the detection of clonal populations of transformed cells in a genomically heterogeneous cellular sample
US5985557A (en) * 1996-01-24 1999-11-16 Third Wave Technologies, Inc. Invasive cleavage of nucleic acids
US5965427A (en) * 1996-01-26 1999-10-12 Genelabs Technologies, Inc. Human RAD50 gene and methods of use thereof
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
US5760012A (en) * 1996-05-01 1998-06-02 Thomas Jefferson University Methods and compounds for curing diseases caused by mutations
US5888983A (en) * 1996-05-01 1999-03-30 Thomas Jefferson University Method and oligonucleobase compounds for curing diseases caused by mutations
AU3495297A (en) * 1996-07-08 1998-02-02 Pioneer Hi-Bred International, Inc. Transformation of zygote, egg or sperm cells and recovery of transformed plants from isolated embryo sacs
US5928870A (en) * 1997-06-16 1999-07-27 Exact Laboratories, Inc. Methods for the detection of loss of heterozygosity
US5952178A (en) * 1996-08-14 1999-09-14 Exact Laboratories Methods for disease diagnosis from stool samples
ES2192672T3 (en) * 1996-11-18 2003-10-16 Takeshi Imanishi NEW ANALOGS OF NUCLEOTIDES.
JP3756313B2 (en) * 1997-03-07 2006-03-15 武 今西 Novel bicyclonucleosides and oligonucleotide analogues
DE69829760T3 (en) 1997-09-12 2016-04-14 Exiqon A/S BI- AND TRI-CYCLIC-NUCLEOSIDE, NUCLEOTIDE AND OLIGONUCLEOTIDE ANALOG
US6010907A (en) * 1998-05-12 2000-01-04 Kimeragen, Inc. Eukaryotic use of non-chimeric mutational vectors
EP1155225B1 (en) 1999-02-24 2003-09-10 N.V. Kema Combustion unit for combusting a liquid fuel and a power generating system comprising such combustion unit
AU777049B2 (en) 1999-03-18 2004-09-30 Qiagen Gmbh Xylo-LNA analogues
US6174683B1 (en) * 1999-04-26 2001-01-16 Biocept, Inc. Method of making biochips and the biochips resulting therefrom
DK1178999T3 (en) 1999-05-04 2007-08-06 Santaris Pharma As L-ribo-LNA analogues
EP1246938A2 (en) * 1999-12-28 2002-10-09 Pangene Corporation Recombinase mediated gene chip detection
CA2400189A1 (en) * 2000-02-11 2001-08-16 Pangene Corporation Integrated genomic services
US6936467B2 (en) 2000-03-27 2005-08-30 University Of Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
AU4948801A (en) 2000-03-27 2001-10-08 Univ Delaware Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
CA2417344A1 (en) 2000-07-27 2002-02-07 University Of Delaware Methods for enhancing targeted gene alteration using oligonucleotides
US20020061530A1 (en) * 2000-07-31 2002-05-23 Belotserkovskii Boris P. Enhanced targeting of DNA sequences by recombinase protein and single-stranded homologous DNA probes using DNA analog activation
AU2002311761B2 (en) 2001-02-21 2007-07-19 Gene Check, Inc. Mutation detection using MutS and RecA
US6428964B1 (en) * 2001-03-15 2002-08-06 Exact Sciences Corporation Method for alteration detection
AU2002303176A1 (en) 2001-03-27 2002-10-15 University Of Delaware Genomics applications for modified oligonucleotides

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5929043A (en) * 1995-01-31 1999-07-27 Pangene Corporation Recombinase mediated DNA therapies
US6245565B1 (en) * 1995-01-31 2001-06-12 Andrey Dayn Recombinase Mediated DNA modifications
US5912340A (en) * 1995-10-04 1999-06-15 Epoch Pharmaceuticals, Inc. Selective binding complementary oligonucleotides
US6335164B1 (en) * 1996-08-29 2002-01-01 Daikin Industries, Ltd. Methods for targeting, enriching, detecting and/or isolating target nucleic acid sequence using RecA-like recombinase
US6200812B1 (en) * 1997-03-21 2001-03-13 Sri International Sequence alterations using homologous recombination
US6107545A (en) * 1998-08-14 2000-08-22 Pioneer Hi-Bred International, Inc. Maize RAD6 genes and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Gene characterization kits", STRATAGENE CATALOG, 1988, pages 39, XP002952219 *
See also references of EP1414840A4 *
USHER M.G. ET AL.: "Targeting of a chimeric oligonucleotide to dsDNA for site-specific gene repair", FASEB JOURNAL, vol. 15, no. 4, March 2001 (2001-03-01), pages A518, ABSTRACT NO. 435.2, XP002952263 *

Also Published As

Publication number Publication date
WO2002079495A2 (en) 2002-10-10
EP1414840A4 (en) 2005-04-13
AU2002303176A1 (en) 2002-10-15
US7229767B2 (en) 2007-06-12
EP1414840A2 (en) 2004-05-06
US20050100921A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
WO2002014485A3 (en) Kallikrein gene
WO2002079495A3 (en) Genomics applications for modified oligonucleotides
AU2002238274A1 (en) Method for the detection of nucleic acid molecules
WO2004101749A3 (en) Methods for amplification of nucleic acid sequences using staggered ligation
AU2002364691A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2002355571A1 (en) Nucleic acid sensor molecules and methods of using same
AU2002256019A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002323612A1 (en) Novel clark protein and nucleic acid molecules and uses therefor
AU2002365759A1 (en) Identification of rearrangements in nucleic acid molecules
AU2002257065A1 (en) Isolated human aminoacylase, nucleic acid molecules encoding human aminoacylase, and uses thereof
WO2002063013A3 (en) Human acid phosphatase gene
AU2002359335A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2002232586A1 (en) Novel s. pyogenes dna polymerase iii holoenzyme nucleic acid molecules and proteins
AU2001292647A1 (en) Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof
AU2002306963A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2002307033A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2002258618A1 (en) Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
AU2002307004A1 (en) Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
AU2002257016A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2002240295A1 (en) Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
AU2003904990A0 (en) Modified gene-silencing nucleic acid molecules and uses thereof
AU2002306884A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2002356870A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2002355825A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
AU2002258619A1 (en) Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 10260150

Country of ref document: US

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10672735

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2002731183

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002731183

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2002731183

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP